Article
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
Cancer research - 1 Mar 2009
Tworoger Shelley S, Gates Margaret A, Gate Margaret A, Lee I-Min, Buring Julie E, Titus-Ernstoff Linda, Cramer Daniel, Hankinson Susan E
Abstract excerpt
Prior studies have suggested that vitamin D may reduce ovarian cancer risk. Thus, we examined whether three single nucleotide polymorphisms (SNP) in the vitamin D receptor (VDR) gene (Fok1, Bsm1, Cdx2) were associated with risk of epithelial ovarian cancer in a retrospective case-control study (New England Case-Control study, NECC) and a nested case-control study of three prospective cohort studies: the Nurses'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
